About MABG Consulting Group
What’s in a Name? MABG represents the perfect intersection of leadership and expertise. While our name is derived from an anagram of our founders’ initials, the sequence of those initials was intentionally chosen to reflect the foundational technologies we serve—signaling that at our firm, the industry’s core science is literally in our DNA.
The People: The combined vision and leadership of founders Mike Garofalo and Arielle Bryan.
The Science: A deliberate play on Monoclonal AntiBodies (mAb) and molecular Genetics — the two pillars of modern diagnostics where we bridge the gap between the lab and commercial reality.
Meet Our Founders
Mike Garofalo — Co-Founder & Chief Executive Officer
Mike Garofalo is a strategic commercial leader with 15+ years of experience driving transformational growth in diagnostics and life science. His career has been defined by one core ability: turning scientific innovation into sustainable revenue.
Most recently serving as North American Sales Director at Medix Biochemica, Mike scaled the regional commercial operation from $8M to $30M+ in revenue; building the sales organization, architecting the go-to-market strategy, and managing a portfolio spanning immunoassay, clinical chemistry, molecular diagnostics, and biological raw materials. He has led commercial operations across every major channel model, including direct sales, distribution, OEM, and strategic partnerships, and has managed some of the largest global accounts in the IVD space.
Before Medix, Mike spent nearly eight years at Enzo Life Sciences, leading North and South American commercial channels and global OEM partnerships totaling $17M in annual revenue.
Mike founded MABG Consulting Group because he saw a gap that kept repeating itself, brilliant science, unclear path to market. He built MABG to close that gap, bringing the commercial rigor, industry relationships, and hands-on execution that growth-stage life science companies need to compete and win.
B.S., Cell and Molecular Biology & Genetics — University of Maryland, College Park
Meet Our Founders
Arielle Bryan, Ph.D. – Co-Founder & Chief Technical Officer
Arielle Bryan is a rare force in the life science industry, a Ph.D. molecular geneticist who speaks the language of commercial strategy as fluently as the language of science. With 18+ years of scientific expertise and 6+ years of market development and commercial leadership experience, she specializes in a genuine, deep understanding of the science behind the product and the strategy required to bring it to market.
Her career spans the full translational arc: from conducting high-impact immunology research at Stony Brook Medicine (cited 600+ times) to driving North American market development for Medix Biochemica. At inGenious Targeting Laboratory, she led the commercialization of a novel antibody platform, securing millions in NIH Phase II SBIR funding.
Her technical expertise spans qPCR, RT-qPCR, NGS, isothermal amplification, immunology, oncology, and infectious disease which enables her to align R&D with the "voice of the customer" at top-tier diagnostic manufacturers. At MABG, she serves as the bridge between the bench and the boardroom, ensuring that every commercial strategy is grounded in scientific credibility and market reality.
Ph.D., Molecular Genetics & Microbiology — Stony Brook University
B.S., Biology (Molecular Biology & Genetics, Research Honors) — Macaulay Honors College, City University of New York
Contact Us
Interested in working together, but not sure who to book time with?
Fill out some info and we will be in touch shortly. We can’t wait to hear from you!
